Report on Accelerating Ebola Vaccine Development: 2015 Recommendations from Wellcome Trust and CIDRAP (cidrap.umn.edu)

• 26-member expert panel developed recommendations across seven key areas.
• Focus on accelerated manufacturing, flexible trial designs, and expedited regulatory pathways.
• African stakeholders should lead ethical decisions and vaccination strategies.

"This February 2015 report by Wellcome Trust and CIDRAP provides expert recommendations to speed up Ebola vaccine development. A 26-member Ebola Vaccine Team B analyzed manufacturing, clinical trials, regulatory pathways, ethics, community engagement, vaccination strategies, and funding. Key recommendations include continuous vaccine attribute assessment, streamlined manufacturing, trials even without efficacy endpoints, WHO-coordinated accelerated approval, African stakeholder leadership in ethics, and phased vaccination of high-risk groups. The report aims to address the West Africa epidemic and prepare for future outbreaks."